Chordoma Foundation

Clinical Trials

For chordoma patients with advanced disease, clinical trials can offer access to promising new treatments, often before they become available in the clinic. In addition to having the potential to benefit from the latest treatments, chordoma patients who participate in clinical trials will help researchers learn about chordoma and how to effectively treat this rare cancer.

In order to help chordoma patients find and enroll in clinical trials, this page lists all clinical trials that are known to be open to chordoma patients. Many of these trials do not explicitly list chordoma in the inclusion criteria, but each has been verified by a trial coordinator to be open to chordoma patients. Before enrolling in a clinical trial it is important to understand the potential risks and benefits, and to discuss your options with your physicians.

To receive email updates about new clinical trials that are open to chordoma patients, click here.

Click here to view clinical trial list in its own browser window

Clinical trials on this page are divided into sections according to phase of the trial:

Phase I: an experimental drug or treatment is tested in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects. Phase I cancer trials are generally open to patients with multiple different types of cancer.

Phase II: an experimental drug or treatment is tested in a larger group of people to see if it is effective and to further evaluate its safety. Phase II cancer trials are generally restricted to patients with a particular type of cancer.

Phase III: a drug or treatment that has shown efficacy in Phase II trials is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.

Useful Information About Clinical Trials

The Chordoma Foundation cannot guarantee the completeness of this list of clinical trials. For more information about clinical trials that you might qualify for, consult with your physician or visit Please contact us if you are aware of additional clinical trials open to chordoma patients.